Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation.
Mukaide M, Tanaka Y, Shin-I T, Yuen MF, Kurbanov F, Yokosuka O, Sata M, Karino Y, Yamada G, Sakaguchi K, Orito E, Inoue M, Baqai S, Lai CL, Mizokami M. Mukaide M, et al. Among authors: karino y. Antimicrob Agents Chemother. 2010 Feb;54(2):882-9. doi: 10.1128/AAC.01061-09. Epub 2009 Nov 23. Antimicrob Agents Chemother. 2010. PMID: 19933798 Free PMC article.
Characterization of novel entecavir resistance mutations.
Hayashi S, Murakami S, Omagari K, Matsui T, Iio E, Isogawa M, Watanabe T, Karino Y, Tanaka Y. Hayashi S, et al. Among authors: karino y. J Hepatol. 2015 Sep;63(3):546-53. doi: 10.1016/j.jhep.2015.03.020. Epub 2015 Mar 25. J Hepatol. 2015. PMID: 25817219
Molecular tracing of Japan-indigenous hepatitis E viruses.
Tanaka Y, Takahashi K, Orito E, Karino Y, Kang JH, Suzuki K, Matsui A, Hori A, Matsuda H, Sakugawa H, Asahina Y, Kitamura T, Mizokami M, Mishiro S. Tanaka Y, et al. Among authors: karino y. J Gen Virol. 2006 Apr;87(Pt 4):949-954. doi: 10.1099/vir.0.81661-0. J Gen Virol. 2006. PMID: 16528044
Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults.
Ito K, Yotsuyanagi H, Yatsuhashi H, Karino Y, Takikawa Y, Saito T, Arase Y, Imazeki F, Kurosaki M, Umemura T, Ichida T, Toyoda H, Yoneda M, Mita E, Yamamoto K, Michitaka K, Maeshiro T, Tanuma J, Tanaka Y, Sugiyama M, Murata K, Masaki N, Mizokami M; Japanese AHB Study Group. Ito K, et al. Among authors: karino y. Hepatology. 2014 Jan;59(1):89-97. doi: 10.1002/hep.26635. Epub 2013 Nov 20. Hepatology. 2014. PMID: 23897861
Case-control study for the identification of virological factors associated with fulminant hepatitis B.
Kusakabe A, Tanaka Y, Mochida S, Nakayama N, Inoue K, Sata M, Isoda N, Kang JH, Sumino Y, Yatsuhashi H, Takikawa Y, Kaneko S, Yamada G, Karino Y, Tanaka E, Kato J, Sakaida I, Izumi N, Sugauchi F, Nojiri S, Joh T, Miyakawa Y, Mizokami M. Kusakabe A, et al. Among authors: karino y. Hepatol Res. 2009 Jul;39(7):648-56. doi: 10.1111/j.1872-034X.2009.00519.x. Epub 2009 Apr 23. Hepatol Res. 2009. PMID: 19456899
Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan.
Ito K, Yotsuyanagi H, Sugiyama M, Yatsuhashi H, Karino Y, Takikawa Y, Saito T, Arase Y, Imazeki F, Kurosaki M, Umemura T, Ichida T, Toyoda H, Yoneda M, Tanaka Y, Mita E, Yamamoto K, Michitaka K, Maeshiro T, Tanuma J, Korenaga M, Murata K, Masaki N, Koike K, Mizokami M; Japanese AHB CHB Study Group. Ito K, et al. Among authors: karino y. J Gastroenterol Hepatol. 2016 Jan;31(1):180-9. doi: 10.1111/jgh.13030. J Gastroenterol Hepatol. 2016. PMID: 26110395
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.
Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H. Matsumoto A, et al. Among authors: karino y. Hepatol Res. 2012 Feb;42(2):139-49. doi: 10.1111/j.1872-034X.2011.00910.x. Epub 2011 Nov 22. Hepatol Res. 2012. PMID: 22103237
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy.
Yuen MF, Heo J, Kumada H, Suzuki F, Suzuki Y, Xie Q, Jia J, Karino Y, Hou J, Chayama K, Imamura M, Lao-Tan JY, Lim SG, Tanaka Y, Xie W, Yoon JH, Duan Z, Kurosaki M, Park SJ, Labio ME, Kumar R, Kweon YO, Yim HJ, Tao Y, Cremer J, Elston R, Davies M, Baptiste-Brown S, Han K, Campbell FM, Paff M, Theodore D. Yuen MF, et al. Among authors: karino y. J Hepatol. 2022 Oct;77(4):967-977. doi: 10.1016/j.jhep.2022.05.031. Epub 2022 Jun 15. J Hepatol. 2022. PMID: 35714812 Free article. Clinical Trial.
IFN-λ3 as a host immune response in acute hepatitis E virus infection.
Murata K, Kang JH, Nagashima S, Matsui T, Karino Y, Yamamoto Y, Atarashi T, Oohara M, Uebayashi M, Sakata H, Matsubayashi K, Takahashi K, Arai M, Mishiro S, Sugiyama M, Mizokami M, Okamoto H. Murata K, et al. Among authors: karino y. Cytokine. 2020 Jan;125:154816. doi: 10.1016/j.cyto.2019.154816. Epub 2019 Aug 26. Cytokine. 2020. PMID: 31465972
Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study.
Suzuki F, Suzuki Y, Karino Y, Tanaka Y, Kurosaki M, Yatsuhashi H, Atarashi T, Atsukawa M, Watanabe T, Enomoto M, Kudo M, Maeda N, Kohno H, Joko K, Michitaka K, Miki K, Takahashi K, Ide T, Fujiyama S, Kohno T, Itoh H, Tsukamoto S, Suzuki Y, Kawano Y, Sugiura W, Kumada H. Suzuki F, et al. Among authors: karino y. BMC Gastroenterol. 2021 Dec 20;21(1):489. doi: 10.1186/s12876-021-02008-9. BMC Gastroenterol. 2021. PMID: 34930140 Free PMC article. Clinical Trial.
129 results